EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC-ND 4.0

Efficacy and safety of AKT inhibitor and anti-androgen therapy in metastatic castration-resistant prostate cancer: a systematic review and meta-analysis

Tulika Ashok Kumar Nahar, Isabella Savin, Nakul Chohan, Maria Bantounou, Niraj Kumar

The Royal College of Radiologists Open · 2023

DOI: 10.1016/j.rcro.2023.100008 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift The Royal College of Radiologists Open, 2023. Verfasst von Tulika Ashok Kumar Nahar und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Nahar, T. A. K., Savin, I., Chohan, N., Bantounou, M., & Kumar, N. (2023). Efficacy and safety of AKT inhibitor and anti-androgen therapy in metastatic castration-resistant prostate cancer: a systematic review and meta-analysis. The Royal College of Radiologists Open. https://doi.org/10.1016/j.rcro.2023.100008

Vancouver

Nahar TAK, Savin I, Chohan N, Bantounou M, Kumar N. Efficacy and safety of AKT inhibitor and anti-androgen therapy in metastatic castration-resistant prostate cancer: a systematic review and meta-analysis. The Royal College of Radiologists Open. 2023. doi:10.1016/j.rcro.2023.100008

BibTeX
@article{Nahar2023,
  author = {Nahar, Tulika Ashok Kumar and Savin, Isabella and Chohan, Nakul and Bantounou, Maria and Kumar, Niraj},
  title = {Efficacy and safety of AKT inhibitor and anti-androgen therapy in metastatic castration-resistant prostate cancer: a systematic review and meta-analysis},
  journal = {The Royal College of Radiologists Open},
  year = {2023},
  doi = {10.1016/j.rcro.2023.100008}
}
Kostenlos starten →